Real-time enrollment status for this metastatic uveal melanoma clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 1:19 PM UTC
| NCT Number | NCT07136181 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Uveal Melanoma |
| Phase | Clinical Trial |
| Target Enrollment | 36 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Novelwise Pharmaceutical Corporation |
| Last Updated on CT.gov | November 28, 2025 (Nov 28, 2025) |
As of July 13, 2026: Clinical trial NCT07136181 is currently recruiting participants. This clinical trial study for metastatic uveal melanoma is actively seeking new participants at 3 locations across the United States. The study is sponsored by Novelwise Pharmaceutical Corporation. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07136181 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07136181 was last updated Nov 28, 2025 (November 28, 2025). HelloStudys verifies this status automatically.